Aberrant glycosylation in IgA nephropathy (IgAN)

被引：144
|
作者：
Coppo, R [1 ]
Amore, A [1 ]
机构：
[1] Osped Regina Margherita, I-10126 Turin, Italy
来源：
KIDNEY INTERNATIONAL | 2004年 / 65卷 / 05期
关键词：
IgA nephropathy; aberrantly glycosylated IgA; pathogenesis of glomerular diseases;
D O I：
10.1111/j.1523-1755.2004.05407.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Immunoglobulin A nephropathy (IgAN) patients exhibit circulating IgA1 with reduced galactose (Gal) and/or sialic acid (Neu5Ac) and increased exposure of N-acetylgalaclosamine (GalNAc). These IgA glycoforms fix complement and in mesangial cells regulate integrin expression, enhance nitric oxide synthase (NOS) activity, decrease endothelial growth factor synthesis, meanwhile depressing proliferation and increasing apoptotis. Drugs can be targeted to the effects enhanced by aberrantly glycosylated IgA1 on mesangial cells. Recent data suggest that aberrant IgA1 glycosylation may modulate clinical expression and progression of IgAN.
引用
收藏
页码：1544 / 1547
页数：4
相关论文
共 50 条
  • [21] Crescentic IgA nephropathy (IgAN) in renal allografts
    Sustento-Reodica, N
    Yuan, S
    Nicosia, RF
    Smith, KD
    Davis, CE
    Alpers, CE
    [J]. MODERN PATHOLOGY, 2002, 15 (01) : 280A - 280A
  • [22] Crescentic IgA nephropathy (IgAN) in renal allografts
    Sustento-Reodica, N
    Yuan, S
    Nicosia, RF
    Smith, KD
    Davis, CE
    Alpers, CE
    [J]. LABORATORY INVESTIGATION, 2002, 82 (01) : 280A - 280A
  • [23] Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients
    Kosztyu, Petr
    Hill, Martin
    Jemelkova, Jana
    Czernekova, Lydie
    Kafkova, Leona Raskova
    Hruby, Miroslav
    Matousovic, Karel
    Vondrak, Karel
    Zadrazil, Josef
    Sterzl, Ivan
    Mestecky, Jiri
    Raska, Milan
    [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2018, 43 (02): : 350 - 359
  • [24] IGA NEPHROPATHY (IGAN) - FAMILIAL CLUSTERING OF ELEVATED IGA PRODUCTION
    WALDO, FB
    BIESCHEL, L
    WEST, CD
    [J]. CLINICAL RESEARCH, 1984, 32 (05): : A910 - A910
  • [25] Presence of ''glomerulophilic IgA1'' in IgA nephropathy (IgAN).
    Hiki, Y
    Kokubo, T
    Iwase, H
    Tanaka, A
    Nishikido, J
    Hotta, K
    Kobayashi, Y
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A2500 - A2500
  • [26] LYMPHOCYTE FUNCTION IN TONSILS IN IGA NEPHROPATHY (IGAN)
    YU, YS
    LI, LS
    [J]. KIDNEY INTERNATIONAL, 1992, 42 (02) : 489 - 489
  • [27] EVALUATION OF THE CLINICAL CLASSIFICATION IN IGA NEPHROPATHY (IGAN)
    YU, YS
    LI, LS
    [J]. KIDNEY INTERNATIONAL, 1992, 42 (02) : 488 - 488
  • [28] ENVIRONMENTAL ANTIGENS (EAG) IN IGA NEPHROPATHY (IGAN)
    GALLA, JH
    RUSSELL, MW
    HAMOND, D
    SPOTSWOOD, M
    MESTECKY, J
    [J]. CLINICAL RESEARCH, 1985, 33 (02): : A585 - A585
  • [29] ENVIRONMENTAL ANTIGENS (EAG) IN IGA NEPHROPATHY (IGAN)
    GALLA, JH
    RUSSELL, MW
    HAMMOND, D
    SPOTSWOOD, M
    MESTECKY, J
    [J]. KIDNEY INTERNATIONAL, 1985, 27 (01) : 210 - 210
  • [30] THE PATTERNS OF SERUM IGA FROM PATIENTS WITH IGA NEPHROPATHY (IGAN)
    QIAN, JQ
    YUN, JM
    YAO, JH
    [J]. KIDNEY INTERNATIONAL, 1992, 42 (02) : 489 - 489
12345